Artificial-Intelligence-Based Radiologic, Histopathologic, and Molecular Models for the Diagnosis and Classification of Malignant Salivary Gland Tumors: A Systematic Review and Functional Meta-Synthesis
Open Access
- 5 April 2026
- journal article
- review article
- Published by MDPI AG in Medical Sciences
- Vol. 14 (2) , 183
Abstract
Background/Objectives: Malignant salivary gland tumors (MSGTs) are rare, biologically heterogeneous neoplasms in which histopathologic diagnosis and classification are challenging and subject to interobserver variability. Artificial intelligence (AI) approaches using radiologic, histopathologic, and molecular data, including radiomics, deep learning, and biomarker-based models, have been proposed as adjunctive diagnostic tools. This systematic review aimed to identify and critically appraise AI/ML models across radiologic, histopathologic, and molecular domains for distinct diagnostic tasks in MSGTs, and to integrate their diagnostic roles through a functional meta-synthesis. Methods: We conducted a PRISMA 2020-compliant systematic review. Embase, PubMed/MEDLINE, and Scopus were searched from inception to February 2026. Eligible studies developed or validated AI/ML diagnostic or classification models in human salivary gland tumor cohorts and reported extractable performance metrics. Results: From 1265 records, eight studies (1922 participants) met the inclusion criteria, spanning CT/MRI radiomics or deep learning (n = 4), whole-slide histopathology deep learning (n = 3), and DNA methylation-based classification (n = 1). External validation was reported in two CT-based benign–malignant discrimination studies, with AUCs of 0.890 (95% CI 0.844–0.937) and 0.745 (95% CI 0.699–0.791). Heterogeneity in model construction, outcome definitions, and validation strategies precluded meta-analysis. Risk of bias was frequently high in QUADAS-2/PROBAST assessments, driven by retrospective sampling, limited blinding, and analysis-related concerns, while calibration and utility were rarely assessed. Conclusions: AI/ML models for MSGTs demonstrate promising diagnostic performance, particularly for preoperative benign–malignant discrimination, but the current evidence base is limited by heterogeneity, predominantly internal validation, and high risk of bias. The functional meta-synthesis identified three convergent diagnostic domains: malignancy discrimination, histopathologic subtype classification, and molecular/epigenetic taxonomy refinement.Keywords
This publication has 37 references indexed in Scilit:
- Development and Evaluation of a Convolutional Neural Network for Microscopic Diagnosis Between Pleomorphic Adenoma and Carcinoma Ex‐Pleomorphic AdenomaHead & Neck, 2024
- DNA Methylation Profiling of Salivary Gland Tumors Supports and Expands Conventional ClassificationLaboratory Investigation, 2024
- Tumeurs des glandes salivaires : OMS 2022 et au-delàAnnales de Pathologie, 2024
- Deep learning–assisted diagnosis of benign and malignant parotid tumors based on contrast-enhanced CT: a multicenter studyEuropean Radiology, 2023
- Ein Vergleich von 4 konvolutionalen neuronalen Netzen in der histopathologischen Diagnostik von SpeicheldrüsenkarzinomenHNO, 2023
- Machine learning–based radiomics for histological classification of parotid tumors using morphological MRI: a comparative studyEuropean Radiology, 2022
- Closing the translation gap: AI applications in digital pathologyBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2021
- Texture‐based and diffusion‐weighted discrimination of parotid gland lesions on MR images at 3.0 TeslaNMR in Biomedicine, 2013
- Radiomics: Extracting more information from medical images using advanced feature analysisEuropean Journal of Cancer, 2012
- The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessedJournal of Clinical Epidemiology, 2005